| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |